Optimal INR level in patients with atrial fibrillation with EHRA type 2 valvular heart disease receiving warfarin

BACKGROUND: To date, there has been no study that compares the efficacy and safety of warfarin in atrial fibrillation (AF) patients with Evaluated Heartvalves, Rheumatic or Artificial (EHRA) type 2 valvular heart disease (VHD). This study was conducted to determine the optimal INR in these patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Luengsupabul, Sirote, Methavigul, Komsing, Methavigul, Ratikorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279990/
https://www.ncbi.nlm.nih.gov/pubmed/32528567
http://dx.doi.org/10.1002/joa3.12342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279990/
https://www.ncbi.nlm.nih.gov/pubmed/32528567
http://dx.doi.org/10.1002/joa3.12342

Ejemplares similares